Thorvardur Halfdanarson

1 month ago | erc.bioscientifica.com | Shruti Chandra |Thorvardur Halfdanarson |Erin Carlson |Kari G. Rabe

Keywords: pancreatic neuroendocrine neoplasms; neuroendocrine cancer; risk factors; panNEN; panNET; nets; NECIntroductionPancreatic neuroendocrine neoplasms (panNENs) are the second most common type of pancreatic cancer, comprising about 2% of cases, with pancreatic ductal adenocarcinoma (PDAC) being the most common type and constitutes roughly 95% of cases (Batcher et al. 2011, Halfdanarson et al. 2014, Antwi et al. 2017).

Jul 19, 2023 | mdpi.com | Albert Jang |Ayse T. Kendi |Geoffrey Johnson |Thorvardur Halfdanarson

Abstract:Radiopharmaceuticals are rapidly developing as a field, with the successful use of targeted beta emitters in neuroendocrine tumors and prostate cancer serving as catalysts. Targeted alpha emitters are in current development for several potential oncologic indications.